Thyrocare Technologies Ltd logo

Thyrocare Technologies Ltd

NSE: THYROCARE BSE: 539871

₹495.50

+12.60 (2.61%)

Sun, 08 Nov 2026, 05:15 am

mtf coin illustrationMTF 5xInvest in Thyrocare Technologies Ltd with 5x LeverageBuy with MTFpremium button ring illustration
Market Cap (in Cr)7678.93
PE Ratio55.42
Dividend1.93
Health ServicesHealth Services
Medical/Nursing ServicesMedical/Nursing Services
24.5K24.5K

Thyrocare Technologies Share Price Live Chart

1 Day

+12.60 (2.61%)

No Result Found

Summary

  • Market Cap (in Cr)

    7850.03

  • Net Profit (in Cr)

    162.85

  • P/B

    10.86

  • Sector P/E

    62.04

  • P/E

    34.16

  • EV/EBITDA

    20.15

  • Debt/Equity (Industry)

    0.21

  • Interest Cover (Industry)

    13.13

  • ROCE (Industry)

    19.39

  • RONW (Industry)

    16.33

  • ROE

    28.77

  • ROCE

    35.35

  • Debt/Equity

    0.07

  • EPS (TTM)

    11.01

  • Dividend Yield

    2.84

  • Book Value

    34.77

  • Interest Cover

    54.76

Financials

Read More

Ratios

Read More

Shareholding

ShareholdersSEPT 2026JUN 2026MAR 2026DEC 2025SEPT 2025
Promoters51.0260.9260.9260.9371.06
FII9.375.445.374.954.85
DII25.9220.9220.9920.5113.47
Public13.7012.7212.7113.6110.63
Government00000

Read More

Technical Analysis

RSI

47.75

MACD

-11.56

50 DMA

530.65

200 DMA

487.19

Support and Resistance

TypeR3R2R1PPS1S2S3
Classic681.13581.63518.97482.13419.47382.63283.13
Fibonacci581.63543.62520.14482.13444.12420.64382.63
Camarilla483.66474.54465.42482.13447.18438.06428.94

Pivots Level: Classic

R3

+199.00

681.13

R2

+99.50

581.63

R1

+36.83

518.97

482.13
482.13
Pivot Point
LTP: 493.10

S1

-62.67

419.47

S2

-99.50

382.63

S3

-199.00

283.13

Moving Average

SMAEMA

Period

Value

  • 10-EMA

    487.48

  • 20-EMA

    493.68

  • 30-EMA

    503.35

  • 50-EMA

    517.59

  • 100-EMA

    522.24

  • 200-EMA

    498.13

Read More

Corporate Actions

Announcement DatePurposeActionEx Date
29 Oct 2026board-meetingsQuarterly Results
05 Jun 2026agm
07 May 2026board-meetingsAccounts, Final Dividend
07 May 2026dividend₹7.00 Dividend /Share23 Jun 2026
28 Jan 2026board-meetingsQuarterly Results
17 Nov 2025bonus2:1 Bonus Issue of Equity Shares28 Nov 2025
28 Oct 2025bonusBonus issue 2:128 Nov 2025
14 Oct 2025dividend₹7.00 Dividend /Share24 Oct 2025
24 Sept 2025dividendInterim Dividend - Rs. - 724 Oct 2025
05 Jul 2025agm

Read More

Peer Comparison

Thyrocare Technologies Ltd logo

Thyrocare Technologies Ltd

Fortis Healthcare Ltd logo

Fortis Healthcare Ltd

Apollo Hospitals Enterprise Ltd logo

Apollo Hospitals Enterprise Ltd

Max Healthcare Institute Ltd logo

Max Healthcare Institute Ltd

Aster DM Quality Care Ltd logo

Aster DM Quality Care Ltd

Read More

Thyrocare Technologies Ltd About

Thyrocare Technologies operates in the healthcare industry and is involved in providing quality diagnostic services to patients.

Industry

Healthcare

Founded

2000

Headquarters

CEO

Rahul Franklin Guha

Employees

Contact

Website icon

Website

http://www.thyrocare.com

Email icon

Email

ramjee.d@thyrocare.com; enquiry@thyrocare.com

Phone icon

Phone

91-22-27622762

Location icon

Location

D-37/1 TTC Industrial Area, MIDC Turbhe, Navi Mumbai, Maharashtra, 400703

Read More

Thyrocare Technologies Ltd Company History

YearHistory
2013
  • EIF acquired certain Equity Shares from Agalia.
  • The Subsidiary commenced operations at the PET-CT centres at Navi Mumbai and conducted over 1,000 scans in the first year of operation.
2014
  • The Company had installed, India’s first and the world’s longest track automation system for seamless sample movements from Siemens Limited.
  • The Company commissioned the operations in medical cyclotron facility in Navi Mumbai.
  • The Subsidiary commenced operations at the PET-CT centres in New Delhi and Hyderabad and the PET-CT centres at New Delhi conducted over 1,000 scans in the first year of operations.
2015
  • The Company opened RPLs in Delhi, Coimbatore, Hyderabad and Kolkata to expand its coverage and volume of tests and samples processed daily.
  • The Company acquired the equipment for testing of water samples and commenced operating the equipment under the brand name 'WHATERS'.
  • The Subsidiary has completed over 10,000 scans at the PET-CT centres in New Delhi, over 10,000 scans at the PET-CT centres in Navi Mumbai from the date of inception and over 1,000 scans at the PET-CT centres in Hyderabad since inception.
2016
  • Thyrocare Technologies are listed and admitted to dealings on the Exchange in the list of 'B' Group Securities.
2024
  • Thyrocare Technologies Completed acquisition of Think Health Diagnostic Private Limited.

Read More

Deals

Client NameDeal TypeOrder SideQTYAvg PriceDate
CITIGROUP GLOBAL MARKETS MAURITIUS PRIVATE LIMITEDblockBuy40100062413 Aug 2026
WHITEOAK CAPITAL MUTUAL FUNDblockBuy64100062413 Aug 2026
TATA AIA LIFE INSURANCE COMPANY LIMITEDblockBuy48100062413 Aug 2026
MORGAN STANLEY ASIA SINGAPORE PTEblockBuy45600062413 Aug 2026
ADITYA BIRLA SUN LIFE MUTUAL FUNDblockBuy65000062413 Aug 2026
ALPHA ALTERNATIVES EQUITY ABSOLUTE RETURN FUNDblockBuy44871762413 Aug 2026
ASHOKA WHITEOAK ICAV-ASHOKA WHITEOAK EMERGING MARKETS EQUITY FUNDblockBuy56100062413 Aug 2026
DSP MUTUAL FUNDblockBuy132136362413 Aug 2026
MORGAN STANLEY ASIA SINGAPORE PTEblockBuy44484662413 Aug 2026
HBM HEALTHCARE INVESTMENTS (CAYMAN) LTDblockBuy76100062413 Aug 2026

Read More

Thyrocare Technologies Ltd News

Thyrocare shareholders approve land purchase and subsidiary sale

Thyrocare Technologies shareholders passed special resolutions to buy land from Nueclear Healthcare and sell the subsidiary to Trovera Healthcare. Public shareholders approved the divestment under SEBI rules.

29 Oct 2026

companies

Thyrocare Q2FY27: Revenue up 25%, profit dips on impairment

Thyrocare Technologies reported a 25% YoY rise in standalone revenue to ₹256.25 crore for Q2FY27. However, consolidated net profit fell due to a ₹44.98 crore impairment on its Nueclear Healthcare subsidiary.

29 Oct 2026

companies

Thyrocare to sell Nuclear Healthcare stake for ₹141.4 crore

Thyrocare Technologies board approved the sale of its full stake in Nuclear Healthcare Limited to Trovera Healthcare for ₹141.4 crore, alongside property purchases in Gurugram and Hyderabad.

21 Sept 2026

companies

Thyrocare Technologies Q1FY26 Results

Thyrocare Technologies reported a 34% YoY rise in consolidated net profit to ₹51.33 crore for Q1FY26, driven by 24% revenue growth to ₹244.17 crore.

24 Jul 2026

companies

Thyrocare Technologies posts Q4FY27 results

Thyrocare Technologies Limited has made the audio recording of its earnings call available. The discussion covered unaudited financial results for the quarter ended June 30, 2026.

23 Jul 2026

companies

Read More

Frequently Asked Questions

  • 1.What is the stock price of Thyrocare Technologies Ltd?

    As of 08/11/2026 at 10:45 AM, Thyrocare Technologies Ltd shares are trading at ₹495.50.

  • 2.What is the market cap. of Thyrocare Technologies Ltd?

    As of 08/11/2026, the market capitalization of Thyrocare Technologies Ltd is ₹7,678.93 crore.

  • 3.When was Thyrocare Technologies Ltd founded?

    Thyrocare Technologies Ltd was founded in 2000.

  • 4.What are the P/E and P/B ratios of Thyrocare Technologies Ltd?

    As of 08/11/2026, Thyrocare Technologies Ltd has a P/E ratio of 55.42 and a P/B ratio of 10.86.

  • 5.How can I buy shares of Thyrocare Technologies Ltd?

    You can buy shares of Thyrocare Technologies Ltd through Pocketful. Simply open a Demat account, complete your KYC, add funds, and place a buy order.

  • 6.What is the shareholding pattern of Thyrocare Technologies Ltd?

    As of September,2026, promoters hold 51.02% in Thyrocare Technologies Ltd, while FIIs, DIIs and public shareholders hold 9.37%, 25.92% and 13.70%, respectively.

  • 7.Does Thyrocare Technologies Ltd pay dividends?

    Yes, Thyrocare Technologies Ltd pays dividends to eligible shareholders. The latest dividend announced by the company was ₹₹7.00 Dividend /Share per share.

  • 8.What is the dividend yield of Thyrocare Technologies Ltd?

    As of 08 November, 2026, the dividend yield of Thyrocare Technologies Ltd stands at 1.93%.

  • 9.What are the latest financial results of Thyrocare Technologies Ltd?

    For the financial year ended March 2025, Thyrocare Technologies Ltd reported revenue of ₹687.00 crore and a net profit of ₹91.51 crore.

  • 10.What is the Stock symbol of Thyrocare Technologies Ltd?

    THYROCARE is the stock symbol of Thyrocare Technologies Ltd.

  • 11.Who is the CEO of Thyrocare Technologies Ltd?

    The CEO of Thyrocare Technologies Ltd is Rahul Franklin Guha.

pocketful logo lightpocketful logo dark
PricingBecome a Partner
search icon
/

No results for ''

Popular search

  • popular search iconSuzlon Energy Ltd
  • popular search iconIndian Railway Finance Corporation Ltd
  • popular search iconTata Motors Ltd
  • popular search iconTata Steel Ltd
  • popular search iconRail Vikas Nigam Ltd

Recent search

      Log In
      search icon

      No results for ‘’

        Popular search

        • popular search iconSuzlon Energy Ltd
        • popular search iconIndian Railway Finance Corporation Ltd
        • popular search iconTata Motors Ltd
        • popular search iconTata Steel Ltd
        • popular search iconRail Vikas Nigam Ltd
        • popular search iconReliance Industries Ltd
        pocketful logo lightpocketful logo dark
        • Pricing
        • Become a Partner
        Log In
        • home icon
        • arrow iconstocks
        • arrow iconthyrocare technologies ltd
        • Overview
        • Analysis
        • Financials
        • Ratios
        • shareholding
        • Technical Analysis
        • Corporate Actions
        • Peer Comparison
        • About
        • Company History
        • Deals
        • News
        • FAQs

        Open Your Free Demat Account Now!

        Step into a world of zero fees and limitless opportunities!

        pocketful logo

        • Quick Links

          • Open Demat Account
          • Pocketful Web
          • Pocketful App
          • Pricing
          • Authorised Person
          • Pocketful Calculators
          • Compliance Links

        • Pages

          • Tools
          • Blogs
          • ETF Screener
          • IPO
          • ETF
          • Bonds
          • Index Heat Map

        • Products

          • Stocks
          • Commodity
          • Subscription
          • Free Stock Screener
          • Pocketful GPT
          • MTF
          • Mutual Funds

        • Company

          • About us
          • Contact us
          • Terms and Conditions
          • Policies & Procedures
          • Privacy Policy
          • Disclosure
          • Careers

        • Socials

          • Facebook iconFacebook
          • Twitter iconTwitter
          • Instagram iconInstagram
          • LinkedIn iconLinkedIn
          • Youtube iconYoutube

        2022-25 Pocketful. All rights reserved, Built with in India

        Version -5.76

        app image 1app image 2

        Stocks:

        AllABCDEFGHIJKLMNOPQRSTUVWXYZ

        Explore

        Calculators
        Popular Calculators
        Group Stocks
        Asset Management Companies
        Popular Stocks
        Indian Indices
        Sector Wise Stocks
        IPO
        Share Market
        Best MF Schemes
        Platforms
        Resources
        Gold Rates in Top Cities
        Silver Rates in Top Cities

        Others:

        NSEBSECDSLNSDLSEBIMCXMSEINCDEXNSE IFSCINDIA INXAccount Closure FormDP Investor CharterBroker Investor Charter

        Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800